Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib

por Mortensen, Anja Charlotte Lundgren, Mohajershojai, Tabassom, Hariri, Mehran, Pettersson, Marika, Spiegelberg, Diana
Publicado 2020

Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer

por Mortensen, Anja Charlotte Lundgren, Berglund, Hanna, Hariri, Mehran, Papalanis, Eleftherios, Malmberg, Christer, Spiegelberg, Diana
Publicado 2023

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells

por Mortensen, Anja Charlotte Lundgren, Spiegelberg, Diana, Brown, Christopher John, Lane, David Philip, Nestor, Marika
Publicado 2019

The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach

por Spiegelberg, Diana, Abramenkovs, Andris, Mortensen, Anja Charlotte Lundgren, Lundsten, Sara, Nestor, Marika, Stenerlöw, Bo
Publicado 2020

The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer Model

por Spiegelberg, Diana, Mortensen, Anja Charlotte Lundgren, Palupi, Kartika Dyah, Micke, Patrick, Wong, Julin, Vojtesek, Borivoj, Lane, David Philip, Nestor, Marika
Publicado 2020